LEXX
Lexaria Bioscience Corp.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No N-PORT holders.
No thesis.
Lexaria Bioscience Corp.
3.60
Largest filed tie
—
Expected move
No implied move.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Invenomic Capital ManagementInvenomic | $193,584 | 21.56% | −21.84% | |
| 2 | Vanguard Capital ManagementVanguardindex-like | $167,124 | 18.61% | +34.25% | |
| 3 | Geode Capital ManagementGeodeindex-like | $140,253 | 15.62% | −14.87% | |
| 4 | Citadel AdvisorsCitadel | $87,889 | 9.79% | +1061.44% | |
| 5 | Toronto Dominion BankToronto Dominion Bank | $56,077 | 6.25% | −28.57% | |
| 6 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $52,733 | 5.87% | 0.00% | |
| 7 | HRT FinancialHRT Financial | $36,000 | 4.01% | +252.28% | |
| 8 | UBS GroupUBS | $26,301 | 2.93% | −10.89% | |
| 9 | Northern TrustNorthern Trustindex-like | $22,302 | 2.48% | +116.57% | |
| 10 | State StreetState Streetindex-like | $22,009 | 2.45% | 0.00% | |
| 11 | Intl FcstoneIntl Fcstone | $15,541 | 1.73% | new | |
| 12 | BlackRockBlackRockindex-like | $15,369 | 1.71% | 0.00% | |
| 13 | XTX TopcoXTX Topco | $12,487 | 1.39% | −11.05% | |
| 14 | Virtu FinancialVirtu Financial | $11,000 | 1.23% | new | |
| 15 | Renaissance TechnologiesRenaissance Technologies | $9,240 | 1.03% | +1.23% | |
| 16 | Susquehanna International GroupSusquehanna International | $8,547 | 0.95% | new | |
| 17 | Bank of MontrealBank of Montreal | $7,858 | 0.88% | 0.00% | |
| 18 | Vanguard Global AdvisersVanguard Globalindex-like | $5,714 | 0.64% | 0.00% | |
| 19 | Royal Bank of CanadaRoyal Bank of Canada | $4,000 | 0.45% | +0.27% | |
| 20 | Crews Bank & TrustCrews Bank & Trust | $2,164 | 0.24% | new | |
| 21 | Advisor Group HoldingsAdvisor | $1,228 | 0.14% | +262.81% | |
| 22 | Federation des caisses Desjardins du QuebecFederation des caisses Desjardins du Quebec | $214 | 0.02% | 0.00% | |
| 23 | FMRFMR | $119 | 0.01% | new | |
| 24 | Tower Research Capital LLC (TRC)Tower Research Capital LLC (TRC) | $85 | 0.01% | +7500.00% | |
| 25 | BarclaysBarclays | $52 | 0.01% | new |
26 managers report $897,897 of Lexaria Bioscience on form 13F for the quarter ended Jun 30 '26. 7 of them hold 80% of it; Invenomic is largest at 21.56%.